Pegylated interferon for chronic hepatitis C
24 results
1 - 24
Interferon for acute hepatitis C: Cochrane systematic review- Interferon for interferon naive patients with chronic hepatitis C: Cochrane systematic review
- Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C: Cochrane systematic review
- Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C: Cochrane systematic review
Interferon for chronic hepatitis C - Ribavirin plus interferon versus interferon for chronic hepatitis C New search for studies and content updated (no change to conclusions)
- Pharmacological interventions for acute hepatitis C infection New search for studies and content updated (no change to conclusions)
- Nitazoxanide for chronic hepatitis C Edited (no change to conclusions)
- Aminoadamantanes versus other antiviral drugs for chronic hepatitis C: Cochrane systematic review
- Bile acids for viral hepatitis Edited (no change to conclusions)
- Aminoadamantanes for chronic hepatitis C: Cochrane systematic review
- Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation: Cochrane systematic review
- Interventions for dialysis patients with hepatitis C virus (HCV) infection New search for studies and content updated (conclusions changed)
- Viral hepatitis
- Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C: Cochrane systematic review
- Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients: Cochrane systematic review